X0202 SCHEDULE 13G 0001781002 XXXXXXXX LIVE Common Shares 03/31/2026 0000748592 ERNEXA THERAPEUTICS INC. 114082308 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 Rule 13d-1(b) Bleichroeder LP DE 80000 0 80000 0 80000 N 6.86 IA Bleichroeder Holdings LLC DE 80000 0 80000 0 80000 N 6.86 HC Andrew Gundlach X1 80000 0 80000 0 80000 N 6.86 HC ERNEXA THERAPEUTICS INC. 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA 02141 Bleichroeder Holdings LLC Bleichroeder LP Andrew Gundlach 1345 Avenue of the Americas, 47th Floor New York, NY 10105 Bleichroeder Holdings LLC and Bleichroeder LP: Delaware, USA Andrew Gundlach: United States N IA HC See cover page. See cover page. See cover page. See cover page. See cover page. See cover page. Y N N Bleichroeder LP ("Bleichroeder"), an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, is deemed to be the beneficial owner of 80,000 shares, or 6.86%, of the common stock (the "Common Stock") of Ernexa Therapeutics, Inc. (the "Issuer") reported as outstanding. Bleichroeder is the beneficial owner of Common Stock and warrants subject to a 4.99% limitation on the exercise of such warrants. If there was no 4.99% limitation on the exercise of such warrants, Bleichroeder would be deemed to be the beneficial owner of 160,000 shares of Common Stock, consisting of 80,000 shares of Common Stock and 80,000 shares of Common Stock issuable upon exercise of the warrants subject to a 4.99% limitation, representing approximately 12.84% of the Issuer's outstanding shares of Common Stock. Clients of Bleichroeder have the right to receive and the ultimate power to direct the receipt of dividends from, or the proceeds of the sale of, such securities. N See Exhibit 99.2 Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1 AGREEMENT OF THE REPORTING PERSONS Exhibit 99.2 JOINT FILING AGREEMENT Bleichroeder LP Andrew Gundlach 05/14/2026 Bleichroeder Holdings LLC Andrew Gundlach 05/14/2026 Andrew Gundlach Andrew Gundlach 05/14/2026